Recent Finacing
Recent Raise
Aerovance is a Berkeley-based biotech developing inhaled therapies for asthma—lead candidate Aerovant is in phase 2 trials—also advancing an eczema drug while seeking development partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors